Clinical Trial Update: Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of the investigational drug MK-7680 in participants with hepatitis C; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MK-7680 (MK-7680)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED